Comments on "Secretin and Autism: A Two-Part Clinical Investigation" by M. G. Chez et al

Comments on "Secretin and Autism: A Two-Part Clinical Investigation" by M. G. Chez et al

This response to Chez et al. (EC 625 006) suggests that the data provided by their study of the gastrointestinal hormone secretin in the treatment of autism do not support the negative conclusions reported. It identifies methodological problems that biased the results toward a negative outcome and c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of autism and developmental disorders 2000-04, Vol.30 (2)
1. Verfasser: Rimland, Bernard
Format: Artikel
Sprache:eng
Schlagworte:
Autism
Drug Therapy
Outcomes of Treatment
Research Methodology
Secretin
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This response to Chez et al. (EC 625 006) suggests that the data provided by their study of the gastrointestinal hormone secretin in the treatment of autism do not support the negative conclusions reported. It identifies methodological problems that biased the results toward a negative outcome and concludes that secretin appears to be a safe and beneficial treatment for autism. (DB)
ISSN:0162-3257
DOI:10.1023/A:1005447203394